Tainted Blood Drug to Face Import Tests
The Food and Drug Administration said Friday that all heparin products being imported into the United States would be stopped and tested for a possibly dangerous contaminant. The action comes after the agency’s inspectors in China found the contaminant in 20 of the 28 lots of the drug’s active ingredient inside a plant that supplied it to much of the American market.
By WALT BOGDANICH
15 March 2008